##gff-version 3
##sequence-region P46527 1 198
P46527	UniProtKB	Chain	1	198	.	.	.	ID=PRO_0000190084;Note=Cyclin-dependent kinase inhibitor 1B	
P46527	UniProtKB	Region	51	91	.	.	.	Note=Interaction with CDK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28666995;Dbxref=PMID:28666995	
P46527	UniProtKB	Motif	153	169	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P46527	UniProtKB	Modified residue	10	10	.	.	.	Note=Phosphoserine%3B by UHMK1;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:10831586,ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:14504289;Dbxref=PMID:23186163,PMID:10831586,PMID:12042314,PMID:12093740,PMID:14504289	
P46527	UniProtKB	Modified residue	74	74	.	.	.	Note=Phosphotyrosine%3B by SRC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17254967;Dbxref=PMID:17254967	
P46527	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphotyrosine%3B by ABL%2C LYN%2C SRC and JAK2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16195327,ECO:0000269|PubMed:17254966,ECO:0000269|PubMed:17254967,ECO:0000269|PubMed:21423214;Dbxref=PMID:16195327,PMID:17254966,PMID:17254967,PMID:21423214	
P46527	UniProtKB	Modified residue	89	89	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16195327;Dbxref=PMID:16195327	
P46527	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphothreonine%3B by CaMK1%2C PKB/AKT1 and PIM1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12244301,ECO:0000269|PubMed:12244303,ECO:0000269|PubMed:18593906,ECO:0000269|PubMed:23707388;Dbxref=PMID:12244301,PMID:12244303,PMID:18593906,PMID:23707388	
P46527	UniProtKB	Modified residue	170	170	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P46414	
P46527	UniProtKB	Modified residue	187	187	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1%2C CDK1 and CDK2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323868,ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:16209941,ECO:0000269|PubMed:23478441;Dbxref=PMID:10323868,PMID:12042314,PMID:16209941,PMID:23478441	
P46527	UniProtKB	Modified residue	198	198	.	.	.	Note=Phosphothreonine%3B by CaMK1%2C PKB/AKT1%2C RPS6KA1%2C RPS6KA3 and PIM1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:14504289,ECO:0000269|PubMed:15280662,ECO:0000269|PubMed:18593906,ECO:0000269|PubMed:23707388;Dbxref=PMID:12042314,PMID:14504289,PMID:15280662,PMID:18593906,PMID:23707388	
P46527	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_011871;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.4;Dbxref=dbSNP:rs2066828	
P46527	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_064429;Note=Found in a patient with multiple endocrine tumors%3B germline mutation%3B reduced expression levels%3B shows impaired binding to CDK2. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20824794;Dbxref=dbSNP:rs777354267,PMID:20824794	
P46527	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_011872;Note=V->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|Ref.3,ECO:0000269|Ref.4;Dbxref=dbSNP:rs2066827,PMID:15489334	
P46527	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Loss of phosphorylation by UHMK1. No translocation to the cytoplasm. Greater cell cycle arrest. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:15280662;Dbxref=PMID:12042314,PMID:12093740,PMID:15280662	
P46527	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Exported to the cytoplasm. Inhibits cell cycle arrest. S->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:15280662;Dbxref=PMID:12042314,PMID:12093740,PMID:15280662	
P46527	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Increased stability in vivo and in vitro. S->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:15280662;Dbxref=PMID:12042314,PMID:12093740,PMID:15280662	
P46527	UniProtKB	Mutagenesis	74	74	.	.	.	Note=No change in binding CDK4 and no inhibition of CDK4 activity. Translocates to nucleus. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16195327,ECO:0000269|PubMed:19075005;Dbxref=PMID:16195327,PMID:19075005	
P46527	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Abolishes LYN-mediated phosphorylation%2C reduces CDK2-mediated phosphorylation on T-187%2C has greater cell cycle arrest into S-phase%2C no effect on binding CDK2 complexes%2C reduced CDK4 binding and inhibits CDK4 enzyme activity. No nuclear translocation. No effect on in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding%3B when associated with F-89. Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16195327,ECO:0000269|PubMed:17254966,ECO:0000269|PubMed:19075005;Dbxref=PMID:16195327,PMID:17254966,PMID:19075005	
P46527	UniProtKB	Mutagenesis	89	89	.	.	.	Note=No effect on binding CDK2 complexes%2C reduced CDK4 binding and greatly inhibits CDK4 enzyme activity. No nuclear translocation. Inhibits in vitro phosphorylation of CDK4 by CCNH-CDK7. Completely abolishes CDK4 binding%3B when associated with F-88. Y->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16195327,ECO:0000269|PubMed:17254966,ECO:0000269|PubMed:19075005;Dbxref=PMID:16195327,PMID:17254966,PMID:19075005	
P46527	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Greatly reduced PKB/AKT1-mediated phosphorylation. Nuclear location. Inhibits cyclin E/CDK2 cell cycle progression. No effect on binding AKT1. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation%3B when associated with A-198. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12244301,ECO:0000269|PubMed:12244303,ECO:0000269|PubMed:14504289,ECO:0000269|PubMed:15280662;Dbxref=PMID:12042314,PMID:12244301,PMID:12244303,PMID:14504289,PMID:15280662	
P46527	UniProtKB	Mutagenesis	161	161	.	.	.	Note=No change in PKB/AKT1-mediated phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12244301;Dbxref=PMID:12244301	
P46527	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No change in PKB/AKT1-mediated phosphorylation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12244301;Dbxref=PMID:12244301	
P46527	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Strongly reduced ubiquitination by a TRIM21-containing SCF(SKP2) complex. E->A%2CD%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16209941;Dbxref=PMID:16209941	
P46527	UniProtKB	Mutagenesis	187	187	.	.	.	Note=No change in PKB/AKT1- nor UHMK1-mediated phosphorylation. T->A%2CD;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:15280662,ECO:0000269|PubMed:16209941,ECO:0000269|PubMed:16880511;Dbxref=PMID:12042314,PMID:12093740,PMID:15280662,PMID:16209941,PMID:16880511	
P46527	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Abolishes phosphorylation-dependent ubiquitination. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:12093740,ECO:0000269|PubMed:15280662,ECO:0000269|PubMed:16209941,ECO:0000269|PubMed:16880511;Dbxref=PMID:12042314,PMID:12093740,PMID:15280662,PMID:16209941,PMID:16880511	
P46527	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Abolishes PKB/AKT1-mediated phosphorylation. 46%25 cytoplasmic location. Greatly reduced binding to YWHAQ. Equally reduced binding%3B when associated with A-10 and A-187. No nuclear import%3B when associated with A-157. Completely abolishes PKB/AKT1-mediated phosphorylation and no cytoplasmic translocation%3B when associated with A-157. T->A%2CD;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12042314,ECO:0000269|PubMed:14504289,ECO:0000269|PubMed:15280662;Dbxref=PMID:12042314,PMID:14504289,PMID:15280662	
P46527	UniProtKB	Sequence conflict	22	22	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P46527	UniProtKB	Helix	38	47	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATH	
P46527	UniProtKB	Turn	50	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JSU	
P46527	UniProtKB	Helix	55	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATH	
P46527	UniProtKB	Turn	64	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATH	
P46527	UniProtKB	Beta strand	71	78	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATH	
P46527	UniProtKB	Helix	86	89	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JSU	
